Evidence map›Paper›PMID 20305759›Full record

ArticleHepatology international2010

Outcomes for patients following hepatic resection of metastatic tumors from gastric cancer.

Hironori Tsujimoto, Takashi Ichikura, Satoshi Ono, Hidekazu Sugasawa, Shuichi Hiraki, Naoko Sakamoto, Yoshihisa Yaguchi, Kazuo Hatsuse, Junji Yamamoto, Kazuo Hase

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Hepatology international, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Role of hepatectomy in gastric cancer with multiple liver-limited metastases.Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2018
    Article
  17. Article
  18. The role of surgery in the therapeutic approach of gastric cancer liver metastases.Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology · 2016
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Hironori TsujimotoDepartment of Surgery, National Defense Medical College, 3-2 Namiki, Tokorozawa, 359-8513 Japan. tsujihi@ndmc.ac.jp
Takashi Ichikura
Satoshi Ono
Hidekazu Sugasawa
Shuichi Hiraki
Naoko Sakamoto
Yoshihisa Yaguchi
Kazuo Hatsuse
Junji Yamamoto
Kazuo Hase

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeAlthough several studies have reported the efficacy of hepatic resection for the long-term survival of patients with gastric cancer metastases, the optimal treatment remains to be determined.

methodsSeventeen patients underwent a hepatic resection for gastric cancer metastases at the National Defense Medical College Hospital. We retrospectively analyzed the clinical outcomes of surgical resection and identified factors associated with prognosis for patients who underwent hepatectomy for gastric cancer metastases.

resultsIn 17 patients, the accumulated 5-year survival rate after hepatic resection was 31.5% and the median survival time was 34 months. Univariate and multivariate analyses showed that gastric tumors less than 6.0 cm and D2 lymphadenectomy were the most important predictors of survival. The five patients who survived more than 5 years after hepatic resection had a D2 lymphadenectomy, modest lymphatic invasion, primary gastric tumors less than 6.0 cm, and a solitary liver metastasis.

conclusionAlthough recent progress in adjuvant therapy should be the key to a good prognosis, we believe that surgical resection may bring some hope of long-term survival for judiciously selected patients with hepatic metastases from gastric cancer.

Indexed as

Gastric cancerHepatectomyLiver metastasisPrognosis

Identifiers

PMID20305759
PMCPMC2836442

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.